NCT03138161: SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 250 planned
- Started
- 13 Apr 2017
- Primary completion
- 31 Dec 2030
- Arms
- Phase 1
- Results
- None posted
- 13 Apr 2017: Trial started
- 3 May 2017: Trial registered